Home | News | 23.04.2026


First patent of the University "St. Cyril and Methodius" in Skopje in the field of pharmacy

The University 'St. Cyril and Methodius' in Skopje has made a significant scientific breakthrough by obtaining its first patent in the field of pharmacy and medicine.
chemistry, which represents an important moment for the oldest and largest higher education institution in the country.

🍀The patent entitled "Coumarin-1,2,3-triazol-isatin hybrid molecules and their applications" relates to the development of a new generation of hybrid compounds with
Potential for application in the treatment of neurodegenerative diseases, including Alzheimer's disease. The compounds act as inhibitors of key enzymes and open up new prospects for the development of more effective therapies.

✅ This invention represents a modern scientific approach based on a multi-target strategy, which allows a single compound to act on multiple biological targets.
simultaneously, a concept that is at the centre of the latest trends in drug development.

🏅The invention is the result of the research work of Prof. Dr Ana Poceva Panovska and Assoc. Prof. Dr Aleksandar Dimkovski from the Faculty of Pharmacy at UGM.

This achievement not only marks the first patent of the Faculty of Pharmacy, but also the first patent of the University 'St. Cyril and Methodius' in Skopje in this field, confirming the scientific maturity and innovative potential of the academic community.

✅ With this significant step, UGJK positions itself as an active player in creating innovative solutions with potential for future development and societal contribution, as well as for the transfer of knowledge towards practical application and opening up opportunities for new collaborations with research and industrial partners.